High Blood Sugar Triggers Pancreatic Cells to Produce the Opioid Peptide Dynorphin

Pancreatic beta-cells respond to high glucose by producing and secreting dynorphin, an opioid peptide that may serve as a feedback signal in blood sugar regulation.

Josefsen, K et al.·Endocrinology·1998·Preliminary Evidencein-vitro
RPEP-00467In VitroPreliminary Evidence1998RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Glucose stimulation induced prodynorphin gene expression in pancreatic beta-cell lines, with dynorphin peptides being processed and secreted, suggesting a novel opioid-mediated feedback mechanism in glucose regulation.

Key Numbers

How They Did This

In-vitro study using subtraction cloning to identify glucose-induced genes in pancreatic beta-cell lines. Dynorphin expression and secretion were confirmed with immunoassays and molecular analysis.

Why This Research Matters

The discovery that beta-cells produce opioid peptides in response to glucose reveals a previously unknown layer of blood sugar regulation that could have implications for understanding diabetes and developing new treatments.

The Bigger Picture

The connection between opioid peptides and blood sugar regulation is poorly understood. If dynorphin acts as a feedback signal from beta-cells, it could explain some of the complex interactions between the opioid system and metabolic health, including why opioid medications sometimes affect blood sugar.

What This Study Doesn't Tell Us

In-vitro study using cell lines, not intact pancreatic tissue. The functional role of secreted dynorphin was not determined. Cell line behavior may differ from normal beta-cells.

Questions This Raises

  • ?Does dynorphin secreted by beta-cells act on nearby cells to regulate insulin release?
  • ?Is this opioid pathway disrupted in type 2 diabetes?
  • ?Could targeting dynorphin signaling offer a new approach to blood sugar management?

Trust & Context

Key Stat:
20 of 53 clones Prodynorphin was by far the most commonly induced gene in glucose-stimulated beta-cells
Evidence Grade:
Preliminary evidence from an in-vitro cell line study with novel gene discovery findings that need in-vivo confirmation.
Study Age:
Published in 1998. The opioid-pancreas connection remains an active but still incompletely understood area of research.
Original Title:
Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin.
Published In:
Endocrinology, 139(10), 4329-36 (1998)
Database ID:
RPEP-00467

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is dynorphin?

Dynorphin is a naturally occurring opioid peptide in the body. Unlike endorphins which produce feelings of pleasure, dynorphins are involved in pain modulation, stress responses, and now potentially blood sugar regulation.

What does this mean for diabetes research?

This study reveals that pancreatic cells have a built-in opioid signaling system that responds to blood sugar. If this pathway is disrupted in diabetes, it could represent both a new way to understand the disease and a potential treatment target.

Read More on RethinkPeptides

Cite This Study

RPEP-00467·https://rethinkpeptides.com/research/RPEP-00467

APA

Josefsen, K; Buschard, K; Sørensen, L R; Wøllike, M; Ekman, R; Birkenbach, M. (1998). Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin.. Endocrinology, 139(10), 4329-36.

MLA

Josefsen, K, et al. "Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin.." Endocrinology, 1998.

RethinkPeptides

RethinkPeptides Research Database. "Glucose stimulation of pancreatic beta-cell lines induces ex..." RPEP-00467. Retrieved from https://rethinkpeptides.com/research/josefsen-1998-glucose-stimulation-of-pancreatic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.